Use of Mitomycin C in Ophthalmic Surgery

Purpose: To discuss the application of mitomycin C (MMC) in ophthalmic surgical procedures, including dosage, method of application, reported complications, and follow-up results. Methods: A comprehensive literature search was conducted on PubMed, Google Scholar, and the Cochrane Library without dat...

Full description

Saved in:
Bibliographic Details
Main Authors: Nader Nassiri, Kourosh Sheibani, Sara Kavousnezhad, Saman Nassiri, Ali Azemati, Nariman Nassiri
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-07-01
Series:Journal of Current Ophthalmology
Subjects:
Online Access:https://journals.lww.com/10.4103/joco.joco_283_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839639500116983808
author Nader Nassiri
Kourosh Sheibani
Sara Kavousnezhad
Saman Nassiri
Ali Azemati
Nariman Nassiri
author_facet Nader Nassiri
Kourosh Sheibani
Sara Kavousnezhad
Saman Nassiri
Ali Azemati
Nariman Nassiri
author_sort Nader Nassiri
collection DOAJ
description Purpose: To discuss the application of mitomycin C (MMC) in ophthalmic surgical procedures, including dosage, method of application, reported complications, and follow-up results. Methods: A comprehensive literature search was conducted on PubMed, Google Scholar, and the Cochrane Library without date limitations using keywords: mitomycin, ophthalmic, and surgery. The original articles used as references were first graded using a 0 to 5 grading scale devised by the authors to ensure the uniformity of reference selection. Only those original articles grading 3 or above based on this grading scale were used as references. The last search was conducted in March 2024. Results: MMC has been widely utilized in ophthalmic surgery due to its effects on the wound-healing process. The main current applications include pterygium surgery, glaucoma filtering surgery, surgical treatment of ocular surface tumors, eye alignment surgeries, dacryocystorhinostomy, and corneal refractive surgery. Conclusions: The dosage and duration of MMC application in ophthalmic surgery depend on the specific procedure, with ongoing controversies regarding the optimal dosage. In addition, it is essential to consider complications when evaluating the cost-benefit of MMC use. Further randomized clinical trials with larger sample sizes and longer follow-up periods are warranted, with a specific focus on reducing long-term side effects, refining dosage guidelines, and exploring MMC’s role in combination therapies for various ophthalmic procedures.
format Article
id doaj-art-db5672a6f54e407ea4b9c3b7d55d6a54
institution Matheson Library
issn 2452-2325
language English
publishDate 2024-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Current Ophthalmology
spelling doaj-art-db5672a6f54e407ea4b9c3b7d55d6a542025-07-04T09:14:52ZengWolters Kluwer Medknow PublicationsJournal of Current Ophthalmology2452-23252024-07-0136321122210.4103/joco.joco_283_23Use of Mitomycin C in Ophthalmic SurgeryNader NassiriKourosh SheibaniSara KavousnezhadSaman NassiriAli AzematiNariman NassiriPurpose: To discuss the application of mitomycin C (MMC) in ophthalmic surgical procedures, including dosage, method of application, reported complications, and follow-up results. Methods: A comprehensive literature search was conducted on PubMed, Google Scholar, and the Cochrane Library without date limitations using keywords: mitomycin, ophthalmic, and surgery. The original articles used as references were first graded using a 0 to 5 grading scale devised by the authors to ensure the uniformity of reference selection. Only those original articles grading 3 or above based on this grading scale were used as references. The last search was conducted in March 2024. Results: MMC has been widely utilized in ophthalmic surgery due to its effects on the wound-healing process. The main current applications include pterygium surgery, glaucoma filtering surgery, surgical treatment of ocular surface tumors, eye alignment surgeries, dacryocystorhinostomy, and corneal refractive surgery. Conclusions: The dosage and duration of MMC application in ophthalmic surgery depend on the specific procedure, with ongoing controversies regarding the optimal dosage. In addition, it is essential to consider complications when evaluating the cost-benefit of MMC use. Further randomized clinical trials with larger sample sizes and longer follow-up periods are warranted, with a specific focus on reducing long-term side effects, refining dosage guidelines, and exploring MMC’s role in combination therapies for various ophthalmic procedures.https://journals.lww.com/10.4103/joco.joco_283_23complicationsdosagemitomycin cophthalmicsurgery
spellingShingle Nader Nassiri
Kourosh Sheibani
Sara Kavousnezhad
Saman Nassiri
Ali Azemati
Nariman Nassiri
Use of Mitomycin C in Ophthalmic Surgery
Journal of Current Ophthalmology
complications
dosage
mitomycin c
ophthalmic
surgery
title Use of Mitomycin C in Ophthalmic Surgery
title_full Use of Mitomycin C in Ophthalmic Surgery
title_fullStr Use of Mitomycin C in Ophthalmic Surgery
title_full_unstemmed Use of Mitomycin C in Ophthalmic Surgery
title_short Use of Mitomycin C in Ophthalmic Surgery
title_sort use of mitomycin c in ophthalmic surgery
topic complications
dosage
mitomycin c
ophthalmic
surgery
url https://journals.lww.com/10.4103/joco.joco_283_23
work_keys_str_mv AT nadernassiri useofmitomycincinophthalmicsurgery
AT kouroshsheibani useofmitomycincinophthalmicsurgery
AT sarakavousnezhad useofmitomycincinophthalmicsurgery
AT samannassiri useofmitomycincinophthalmicsurgery
AT aliazemati useofmitomycincinophthalmicsurgery
AT narimannassiri useofmitomycincinophthalmicsurgery